Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandoned, ACIP, addiction, adjustment, Allogene, altering, Alzheimer, anniversary, Argentina, arrangement, arson, avelumab, Azar, Bain, Biopharma, Blueprint, BS, burdensome, Bureau, buyer, cancel, Catalyst, category, Cerevel, CIA, classification, copayment, count, counter, creation, criterion, dan, defendant, demerger, digestive, discontinuance, downgrade, driven, element, epilepsy, evidence, exert, explicitly, extra, faster, genetic, GlaxoSmithKline, GSK, Hall, harbor, hard, House, Hudson, incomplete, index, input, Inspector, intervene, Ixifi, Laboratory, Labour, lawsuit, layer, LIBOR, littman, measured, midterm, mineral, Ministry, misaligned, misuse, municipal, myriad, NMPA, OAI, occupancy, older, operationalize, outweigh, owner, Parkinson, path, PBM, percent, Pharmacology, potency, prevailing, problem, PSI, purity, push, QCE, Quest, qui, ratified, rationalizing, realigning, reclassified, recovery, recruitment, reluctance, representation, rigid, Rod, rule, ruled, ruling, schizophrenia, shortage, shortened, site, skin, Spiral, stake, strictly, suboptimal, succeed, tam, Tegna, tighter, timeline, turn, unconstitutional, upcoming, Upjohn, Urbanization, USMCA, variable, vehicle, viability, vitamin, Welfare, White, WRDM
Removed:
accountable, adherence, Analyst, appointed, auditor, begun, Benchmarking, biosimilarity, caption, career, comparability, comparator, Computation, confirm, consolidate, convention, description, Dev, diminish, disposal, dispose, disposition, elevate, Em, enterprise, Euromonitor, exercise, fergusson, forum, Hill, import, indirect, innovating, interim, introduce, Laurie, low, mechanism, Medicinal, Mexico, migrating, migration, mitigation, modified, Nivestim, Olson, oversaw, planning, proactively, progression, propose, provision, Publication, ratio, real, Rebif, recordkeeping, region, remuneration, resource, restoration, robust, sanger, satisfaction, served, software, Spiriva, standardize, stephen, suggested, sustained, testing, undergo
Filing tables
Filing exhibits
- 10-K Annual report
- 2.2 Stock and Asset Purchase Agreement
- 10.7 Amendment No 1 Pfizer Consolidated Supp Pension Plan for Us & PR Emplys
- 10.12 Amendment No 4 to the Pfizer Supplemental Savings Plan
- 10.13 Amendment No 5 to the Pfizer Supplemental Savings Plan
- 10.26 Amendment No 1 Pfizer Inc Executive Severance Plan
- 10.33 Time Sharing Agreement
- 13 2018 Financial Report
- 21 Subsidiaries of the Company
- 23 Consent of KPMG, Independent Registered Public Accounting Firm
- 31.1 Certification by the Chief Executive Officer - 302
- 31.2 Certification by the Chief Financial Officer - 302
- 32.1 Certification by the Chief Executive Officer - 906
- 32.2 Certification by the Chief Financial Officer - 906
- Download Excel data file
- View Excel data file
Related press release
Associated PFE transcripts
PFE similar filings
Filing view
External links
EXHIBIT 10.12
Amendment No. 4
Pfizer Supplemental Savings Plan (the “PSSP”)
* * *
(New material underlined; deletions crossed out)
1. Section 2.31 shall be clarified to read as follows:
2.31 Regular Earnings.
However, for Pension Transfers, solely for purposes of the Retirement Savings Contribution, Regular Earnings shall not include any bonuses (including but not limited to, sales and GPP bonuses) earnedpaid or deferred in 2018 which reflects payment for services performed in 2017.
2. Section 3.5(c) is clarified to read as follows:
3.5(c) For any Pension Transfer, the definition of “Regular Earnings” in connection solely with the calculation of the 2018 Retirement Savings Contributions under the Plan for such Pension Transfer shall not include any bonuses (including but not limited to, sales and GPP bonuses) earned inpaid to or deferred by such Pension Transfer during 2018 which reflects performance during 2017.